ReviewCell Oncol (Dordr)2020
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.
- Journal
- Cell Oncol (Dordr)
- Published
- 5 June 2020
- Citations
- 91
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background Pancreatic cancer or pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating cancer types with a 5-year survival rate of only 9%. PDAC is one of the leading causes of cancer-related deaths in both genders. … Excerpt only: this text is the publisher’s. Read it in full at the source.